Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 17Neuroblastoma 13Glioblastoma 11Central Nervous System Neoplasms 9Ependymoma 8Brain Neoplasms 7Astrocytoma 7Medulloblastoma 6Osteosarcoma 5Oligodendroglioma 5Ganglioneuroblastoma 5Wilms Tumor 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Non-Hodgkin 4Histiocytosis, Langerhans-Cell 4Hepatoblastoma 4Gliosarcoma 4Sarcoma 3Rhabdomyosarcoma 3Lymphoma 3Glioma, Subependymal 3Breast Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Ovarian Neoplasms 2Neurofibromatosis 1 2

Interventions

vandetanib 2Bevacizumab 2Anthropogenic Effects 2enzastaurin 1carotuximab 1Temozolomide 1Tamoxifen 1Steroids 1Irinotecan 1Carboplatin 1Bortezomib 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Biopsy × CNS × Clear all
NCT07560865 2026-05-01

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Masonic Cancer Center, University of Minnesota

Phase 1 Recruiting
9 enrolled
CNS

Astrocytoma, Glioblastoma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡